<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01141335</url>
  </required_header>
  <id_info>
    <org_study_id>DS-002</org_study_id>
    <nct_id>NCT01141335</nct_id>
  </id_info>
  <brief_title>Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair</brief_title>
  <official_title>Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Infinit® PTFE Mesh, a Prospective Randomized, Double-blind, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of the Lichtenstein's hernioplasty using Infinit® PTFE
      Mesh, and to compare it with the traditional Lichtenstein procedure performed with
      polypropylene mesh.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-hernioplasty acute pain</measure>
    <time_frame>24 hours</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>24 hours</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative acute discomfort</measure>
    <time_frame>24 hours</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>7 days</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>from 24 hours to 5 years</time_frame>
    <description>to monitor any other postoperative complication observed in the immediate, mid-term and long-term postoperative period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence</measure>
    <time_frame>from 1 months to 5 years</time_frame>
    <description>to measure the recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>14 days</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty acute pain</measure>
    <time_frame>72 hours</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty acute pain</measure>
    <time_frame>7 days</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty acute pain</measure>
    <time_frame>14 days</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>1 months</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>3 months</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>6 months</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>1 year</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>2 years</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>3 years</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>4 years</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-hernioplasty chronic pain</measure>
    <time_frame>5 years</time_frame>
    <description>to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), and parenteral/oral analgesic consumption in the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>72 hours</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>7 days</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>14 days</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>1 months</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>3 months</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>6 months</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>1 year</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>2 years</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>3 years</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>4 years</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>5 years</time_frame>
    <description>to measure the physical function score from the SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative acute discomfort</measure>
    <time_frame>72 hours</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative acute discomfort</measure>
    <time_frame>14 days</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>1 months</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>3 months</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>6 months</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>1 year</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>2 years</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>3 years</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>4 years</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative chronic discomfort</measure>
    <time_frame>5 years</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative acute and chronic discomfort</measure>
    <time_frame>7 days</time_frame>
    <description>to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>14 days</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>1 months</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>3 months</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>6 months</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>1 year</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>2 years</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>3 years</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>4 years</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>5 years</time_frame>
    <description>to rate the wound infection risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>1 months</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>3 months</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>6 months</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>1 years</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>2 years</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>3 years</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>4 years</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mesh shrinkage</measure>
    <time_frame>5 years</time_frame>
    <description>to measure the effectiveness shrinkage of the two different mesh using Ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Physical Function</condition>
  <condition>Pain</condition>
  <condition>Hernia</condition>
  <condition>Wound Infection</condition>
  <condition>Postoperative Complication</condition>
  <condition>Recurrence</condition>
  <arm_group>
    <arm_group_label>PTFE mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Lichtenstein tension-free hernioplasty is performed using PTFE mesh</description>
  </arm_group>
  <arm_group>
    <arm_group_label>polypropylene mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A Lichtenstein tension-free hernioplasty is performed using polypropylene mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>polypropylene mesh</intervention_name>
    <description>A Lichtenstein tension-free hernioplasty is performed using a polypropylene mesh will be fixed by sutures in Polypropylene 2/0.</description>
    <arm_group_label>polypropylene mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Infinit® PTFE mesh (WL Gore)</intervention_name>
    <description>A Lichtenstein tension-free hernioplasty is performed using a PTFE mesh will be fixed by sutures in PTFE 2/0.</description>
    <arm_group_label>PTFE mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 &lt;65 years of age

          -  Diagnosis of Unilateral inguinal hernia

          -  Able to provide written consent

          -  BMI &lt; 35

          -  ASA I-II patients

          -  Non-complicated primary inguinal hernia performed in non-emergency setting and
             repaired with a Lichtenstein's hernioplasty

          -  Informed consent

        Exclusion Criteria:

          -  Recurrent hernias

          -  Incarcerated hernia

          -  BMI &gt; 35

          -  ASA III-IV patients

          -  Any condition preventing a correct evaluation of pain (non-cooperative patient, blind
             patient, drug addicted)

          -  Hypersensitivity to any drug in study

          -  Patients with an intra-operative findings of different pathology will be excluded from
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luigi Masoni, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Saverio Mari, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Brescia, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giuseppe R Nigri, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Favi, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Milillo, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Sant'Andrea, Rome, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UO Oneday-day Surgery, Azienda Ospedaliera Sant'Andrea</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2010</study_first_submitted>
  <study_first_submitted_qc>June 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2010</study_first_posted>
  <last_update_submitted>November 20, 2016</last_update_submitted>
  <last_update_submitted_qc>November 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Francesco Saverio Mari</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>shrinkage</keyword>
  <keyword>postoperative pain and discomfort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

